开启主要内容

HKU Joins Hands with China National Pharmaceutical Group Corporation in Translational Pharmaceutical R&D

2011年09月19日

返回新闻

In a signing ceremony organized by the Technology Transfer Office on September 19, 2011, HKU and China National Pharmaceutical Group have signed a strategic cooperation framework agreement. HKU Vice-Chancellor and President Professor Lap-Chee Tsui and President of China National Pharmaceutical Group Corporation Mr She Lulin have been the signees representing the two parties respectively at the ceremony. This is the first time an agreement is signed between HKU and a national pharmaceutical group. The move is an important step to mark the cooperation of the two institutions in translational pharmaceutical research and development. Under the agreement, the Group is granted distribution rights on the Mainland of an HKU developed leukaemia drug and the two institutions will join hands to develop an arrhythmia drug. HKU Vice-Chancellor Professor Lap-Chee Tsui said the agreement would foster collaborations in basic scientific research as well as pharmaceutical development. The University is also planning to send doctoral students on short-term internship at the company.

HKU EEE AI Startup Fano Labs Receives Grand Award of HK ICT Awards 2018

2018年04月16日

返回新闻

返回新闻

STEM and Gifted Education Conference 2016 (9-10 Dec 2016)

2017年01月25日

电子通讯

获取最新技术和新闻

标有星号 (*) 的字段为必填项

如果您不希望再收到我们的电子邮件,您可以发送取消订阅的请求至info@tto.hku.hk.